XML 19 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating activities:        
Net income (loss) $ (390) $ 77 $ (1,684) $ (1,082)
Adjustments to reconcile net income (loss) to net cash provided by operations:        
Depreciation and amortization 259 283 790 887
Impairment of goodwill 600 0 1,000 700
Impairment of long-lived assets and assets held for sale (51) 48 758 310
Net change in operating assets and liabilities 317 (227) (190) (364)
Deferred income taxes – net and uncertain tax positions (53) (199) (666) (349)
Stock-based compensation 29 31 89 93
Other items 2 (5) 597 18
Net loss (gain) from sale of business and long-lived assets (21) (3) (22) (29)
Net cash provided by (used in) operating activities 693 5 672 184
Investing activities:        
Beneficial interest collected in exchange for securitized accounts receivables 339 362 951 1,056
Purchases of property, plant and equipment and intangible assets (148) (149) (369) (407)
Proceeds from sale of business and long-lived assets 38 10 39 68
Acquisition of businesses, net of cash acquired 0 0 (15) 0
Purchases of investments and other assets (1) (38) (56) (44)
Proceeds from sale of investments 40 0 40  
Other investing activities 0 (1) 0 (6)
Net cash provided by (used in) investing activities 268 184 590 667
Financing activities:        
Purchase of shares from non-controlling interests 0 0 (64) 0
Dividends paid to non-controlling interests 0 0 (78) 0
Repayment of senior notes and loans and other long term liabilities 0 (1,000) (956) (4,152)
Proceeds from senior notes, net of issuance costs 0 0 0 2,451
Proceeds from short term debt 0 700 0 700
Repayment of short term debt 0 (200) 0 (200)
Other financing activities 0 (76) (19) (136)
Net cash provided by (used in) financing activities 0 (576) (1,117) (1,337)
Translation adjustment on cash and cash equivalents 100 (33) (53) (98)
Net change in cash, cash equivalents and restricted cash 1,061 (420) 92 (584)
Balance of cash, cash equivalents and restricted cash at beginning of period 2,258 2,670 3,227 2,834
Balance of cash, cash equivalents and restricted cash at end of period 3,319 2,250 3,319 2,250
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:        
Cash and cash equivalents 3,319 2,249 3,319 2,249
Restricted cash included in other current assets 0 1 0 1
Total cash, cash equivalents and restricted cash shown in the statement of cash flows 3,319 2,250 3,319 2,250
Non-cash financing and investing activities:        
Beneficial interest obtained in exchange for securitized accounts receivables 332 376 964 1,090
Dividend declared to non-controlling interests $ 0 $ 67 $ 0 $ 67